Background: A post-acne hyperpigmentation index (PAHPI) has been developed in the United States to better compare therapeutic modalities. Our aim in this study was to validate the PAHPI score in patients with skin type VI from sub-Saharan Africa.
Patients And Methods: The study was conducted in Dakar, Senegal. Twenty-one patients with Fitzpatrick skin type VI, aged 17 to 55 years, presenting hyperpigmentation secondary to acne were included. Ongoing use of skin bleaching products or acne treatments was allowed. Four trained dermatologists rated the patients using the PAHPI. A narrow-band reflectance spectrophotometer (Mexameter MX-18, Cologne, Germany) was used to measure the degree of pigmentation of involved and adjacent skin on 6 representative facial lesions.
Results: The average inter-rater reliability (weighted Kappa) showed substantial agreement for intensity (0.67), moderate agreement for number (0.53) and fair agreement for lesion size (0.28). Inter-rater reliability for the total PAHPI was excellent for both day 1 and day 2 (interclass correlation coefficient of 0.87 and 0.85, respectively; P<0.0001). Intra-rater reliability for total PAHPI ranged from 0.83 to 0.93 (P<0.0001). PAHPI scoring thus demonstrated excellent reliability both between and within raters. The association was moderate to substantial for all raters on both days (range for rho on day 1: 0.531 to 0.815; range for rho on day 2: 0.448 0.762). The correlations between the Mexameter (Courage and Khazaka) measurements and PAHPI scores showed moderate to substantial agreement.
Conclusion: Although tested primarily in African American women to date, PAHPI is also valid for patients from sub-Saharan Africa.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.annder.2022.05.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Efficacy of a 2-MNG-Containing Depigmenting Serum in the Treatment of Post-Inflammatory Hyperpigmentation.
J Cosmet Dermatol
December 2024
La Roche Posay Laboratoire Dermatologique, Levallois-Perret, France.
Background: Post-inflammatory hyperpigmentation (PIHP) predominantly affects patients with melanin-rich skin, significantly impacting them psychosocially due to more frequent and severe pigmentary changes. In this study, the efficacy of a novel depigmenting agent 2-mercaptonicotinoyl glycine (Melasyl) in a dermocosmetic (DC) serum formulation is assessed as a stand-alone treatment of PIHP without sunscreen.
Materials And Methods: Thirty-two Mauritian subjects aged 18-50 years of phototype IV-VI presenting mild acne (GEA2) and moderate to severe PIHP (PAHPI > 10) participated in this study.
Evaluating the Pros and Cons of Fractional CO2 Laser Versus Microneedling in Atrophic Acne Scars in the Skin of Color: A Split Face Study.
Indian Dermatol Online J
October 2024
Department of Dermatology, Byramjee Jeejeebhoy Government Medical College, Pune, Maharashtra, India.
Background: Post-acne scarring causes severe physical and psychological distress. Multiple treatment modalities are available with no single gold standard treatment.
Aim And Objectives: To assess and compare the efficacy and safety of fractional CO2 laser and microneedling in atrophic acne scars and corelate with variables like scar type, duration, and Fitzpatrick skin types.
Background: There are numerous over-the-counter products for treating acne, although many formulations have tolerability issues and lack the cosmetic elegance desired by adult patients.
Objective: The objective of this study was to evaluate the efficacy and tolerability of a non-prescription, active acne regimen in adult patients of all Fitzpatrick skin types.
Method: Thirty-five male and female subjects with Fitzpatrick skin types I-VI were enrolled in this single-site, monadic 8-week study.
Tranexamic Acid for the Treatment of Hyperpigmentation and Telangiectatic Disorders Other Than Melasma: An Update.
Clin Cosmet Investig Dermatol
September 2024
The Institute of Dermatology and Venereology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.
Article Synopsis
- - Tranexamic acid (TXA) is primarily an antifibrinolytic agent used to control bleeding in trauma and surgeries, and it also helps prevent bleeding in hemophilia patients.
- - Recent studies suggest TXA has additional benefits like reducing pigmentation, inflammation, and promoting skin recovery, leading to its exploration as a treatment for various skin issues.
- - The review focuses on TXA's effectiveness for conditions like post-inflammatory hyperpigmentation and rosacea, advocating for its potential use beyond melasma as a safer, cost-effective treatment option.
Article Synopsis
- - The study investigated the psychological impact of acne vulgaris on patients, specifically looking at anxiety, depression, and body dysmorphic disorder (BDD) while assessing the overall quality of life and self-esteem in dermatology patients.
- - Conducted at East Jeddah Hospital in Saudi Arabia, the research used questionnaires to gather data on demographics, acne severity, and psychological conditions, revealing that the majority of participants were young university students with a mean acne duration of about 5.75 years.
- - Results showed that while participants generally had normal self-esteem, many exhibited symptoms of anxiety and depression, and the findings indicated that acne moderately affected their quality of life, with a notably high rate of positive BDD cases among them.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!